NDRG2 Antibody

說明書

中文名稱：

NDRG2兔多克隆抗體
貨號：

CSB-PA071884
規格：

￥1100
圖片：
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA071884(NDRG2 Antibody) at dilution 1/50, on the right is treated with synthetic peptide. (Original magnification: ×200)

The image on the left is immunohistochemistry of paraffin-embedded Human lung cancer tissue using CSB-PA071884(NDRG2 Antibody) at dilution 1/50, on the right is treated with synthetic peptide. (Original magnification: ×200)

Gel: 10%SDS-PAGE, Lysate: 40 μg, Lane: Human brain malignant glioma tissue, Primary antibody: CSB-PA071884(NDRG2 Antibody) at dilution 1/950, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

Uniprot No.：

Q9UN36
基因名：

NDRG2
別名：

Antidepressant related protein ADRG123 antibody; Cytoplasmic protein Ndr1 antibody; DKFZp781G1938 antibody; FLJ25522 antibody; KIAA1248 antibody; N myc downstream regulated gene 2 antibody; N myc downstream regulator 2 antibody; NDR1 related protein NDR2 antibody; NDRG 2 antibody; NDRG family member 2 antibody; NDRG1 related protein antibody; NDRG2 antibody; NDRG2_HUMAN antibody; Protein NDRG2 antibody; Protein Syld709613 antibody; SYLD antibody; Syld709613 protein antibody
宿主：

Rabbit
反應種屬：

Human,Mouse,Rat
免疫原：

Synthetic peptide of Human NDRG2
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
抗體亞型：

IgG
純化方式：

Antigen affinity purification
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
產品提供形式：

Liquid
應用范圍：

ELISA,WB,IHC

推薦稀釋比：

Application	Recommended Dilution
ELISA	1:1000-1:5000
WB	1:500-1:2000
IHC	1:25-1:100

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Contributes to the regulation of the Wnt signaling pathway. Down-regulates CTNNB1-mediated transcriptional activation of target genes, such as CCND1, and may thereby act as tumor suppressor. May be involved in dendritic cell and neuron differentiation.
基因功能參考文獻：
1. NDRG2 knockdown promotes renal fibrosis through its effect on the protein and mRNA expression of epithelial-mesenchymal transition markers. PMID: 28646304
2. Data show that Sentrin/SUMO specific protease (SENP2) interacts with N-myc downstream regulated gene 2 (NDRG2) and mediates the de-SUMOylation process of NDRG2. PMID: 29060933
3. Down-regulation of NDRG2 promotes cancer cell proliferation and neoplasm invasion through regulation by microRNA-454. PMID: 29080452
4. Increased level of NDRG2 in cortex or hippocampus may be a potential risk for Alzheimer's disease. NDRG2 increased Abeta1-42 might be related to the changes of BEAC1 and GGA3. It might also affect CDK5 and tau overphosphorylation. NDRG2 interacting with STAT3 and modulating Fas/Fasl signaling pathway plays important roles in cell death. PMID: 28670853
5. Lower expression of KLF4 and NDRG2 in colorectal cancer patients was correlated with poor overall survival. Thus, KLF4 inhibited the proliferation of colorectal cancer cells dependent on NDRG2 signaling, which provides a novel strategy for therapy and early diagnosis of colorectal cancer. PMID: 28656310
6. NDRG2 could be a potential independent diagnostic biomarker for bladder cancer. PMID: 28953854
7. The different NDRG2 promoter methylation and expression levels in pituitary adenoma samples showed tumor heterogeneity and indicates a potential role of this gene in pituitary adenoma pathogenesis. PMID: 28390436
8. NDRG2 expression decreased in adriamycin resistance breast cancer cells. NDRG2 can promote adriamycin sensitivity by inhibiting proliferation, enhancing cellular damage responses, and promoting apoptosis in a p53-dependent manner. PMID: 28423695
9. Authors investigate the clinical and pathological role of NDRG2 in human malignant tumors. The absence of NDRG2 expression is associated with oncogenic properties through the loss of its role as a tumor suppressor; NDRG2 overexpression inhibits proliferation, adhesion, and invasion, whereas its expression is low or undetectable in various cancers. [Review] PMID: 27113371
10. These findings indicate that SUMOylation of NDRG2 is necessary for its tumor suppressor function in lung adenocarcinoma and that RNF4 increases the efficiency of this process. PMID: 27072586
11. NDRG2 is a novel ERS-responsive protein and acts as PERK co-factor to facilitate PERK branch, thereby contributing to ERS-induced apoptosis. PMID: 28948615
12. Our results show how NDRG2 expression serves as a critical determinant of the invasive and metastatic capacity of oral squamous cell carcinoma (OSCC) PMID: 28209617
13. putative tumor suppressive function of NDRG2 may be confined to luminal- and basal B-type breast cancers PMID: 27400234
14. Overexpression of NDRG2 can inhibit the proliferation. PMID: 28031114
15. present results suggest that hypermethylation in promoter around exon 2 is functioning as essential factors of NDRG2 silencing in gastrointestinal cancers PMID: 28093228
16. NDRG2 overexpression significantly reduced hepatoma cell proliferation and enhanced cell apoptosis under glucose limitation. Moreover, NDRG2 overexpression aggravated energy imbalance and oxidative stress by decreasing the intracellular ATP and NADPH generation and increasing ROS levels. PMID: 28069379
17. The methylation status of the NDRG2 promoter in PBMCs is a potential noninvasive biomarker to predict the severity of liver fibrosis. PMID: 28202850
18. Data show that downregulation of NDRG2 may play an important role in advanced hepatoblastomas. PMID: 26646663
19. Study shows that NDRG2 was significantly down-regulated in glioblastomas (GBM) and seems to play a role in GBM prognosis. The low expression of NDRG2 at the mRNA level leads to a longer progression-free survival independent of methylation status. PMID: 26976975
20. Stuidies indicate the potential of N-myc downstream-regulated gene 2 (NDRG2) as a therapeutic target for cancer. PMID: 26506239
21. NDRG2 overexpression enhanced sodium/iodide symporter level in thyroid tumor cells and increased their iodine uptake in vitro. PMID: 26802650
22. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion. PMID: 26250123
23. miR-301a/b-NDRG2 might be an important axis modulating autophagy and viability of prostate cancer cells under hypoxia. PMID: 26813459
24. Loss of NDRG2 induced the expression of matrix metalloproteinase-19 (MMP-19), which regulated the expression of Slug at the transcriptional level in the epithelial-mesenchymal transition of gallbladder carcinoma cells. PMID: 26292259
25. The forced expression of NDRG2 in ATL cells down-regulates not only the canonical pathway by inhibiting AKT signaling but also the non-canonical pathway by inducing NF-kappaB-inducing kinase (NIK) dephosphorylation via the recruitment of PP2A PMID: 26269411
26. NDRG2 functions as an essential regulator in glycolysis and glutaminolysis via repression of c-Myc, and acts as a suppressor of carcinogenesis. PMID: 26317652
27. This review summarizes the distribution and subcellular localization of NDRG2 in brain tissues, highlights the physiological actions of NDRG2 in the nervous system, and discusses the roles of NDRG2 during the occurrence of nervous system disease. [review] PMID: 26341979
28. NDRG2 suppresses the proliferation of human bladder cancer cells via induction of oncosis. PMID: 26239274
29. Authors found that H. pylori silenced Ndrg2 by activating the NF-kappaB pathway and up-regulating DNMT3b, promoting gastric cancer progression. Findings uncover a previously unrecognized role for H. pylori infection in gastric cancer. PMID: 25823664
30. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer. PMID: 25756511
31. The downregulation of NDRG2 combined with the upregulation of CD24 may play a synergistic role in the occurrence and progression of hepatocellular carcinoma. PMID: 25338637
32. NDRG2 was negatively correlated with Bcl-2 in gastric cancer tissues. PMID: 25854572
33. NDRG2 can significantly inhibit the proliferation of OS-RC-2 cells in vitro and its protein is specifically expressed in the mitochondrion PMID: 24839115
34. these data show that the inhibition of NF-kappaB signaling by NDRG2 expression is able to suppress cell migration and invasion through the down-regulation of COX-2 expression. PMID: 25256221
35. NDRG2/gp130/STAT3 pathway can mediate the antimetastatic effects of Dp44mT in hepatocellular carcinoma. PMID: 25261367
36. findings show NDRG2 expression is downregulated in glioma and level of NDRG2 expression negatively correlates with glioma grade;findings also indicate NDRG2 downregulation may be due to aberrant methylation of NDRG2 promoter region and subsequent transcriptional inactivation PMID: 24840052
37. Data suggest targeting the actions of N-myc downstream-regulated gene 2 (NDRG2) in cell glucose-dependent energy delivery may provide a strategy for therapeutic intervention in breast carcinoma. PMID: 24636131
38. Data show the expression of N-myc downstream-regulated gene 2 (NDRG2) is frequently downregulated in adult T-cell leukaemia-lymphoma, resulting in enhanced phosphorylation of PTEN and activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. PMID: 24569712
39. the inhibition of STAT3 signaling by NDRG2 suppresses EMT progression of EMT via the down-regulation of Snail expression PMID: 25153349
40. Taken together, these data indicate that NDRG2 inhibits the proliferation of neuroblastoma cells partially through suppression of cysteine-rich protein 61. PMID: 24528032
41. NDRG2 overexpression can inhibit tumor growth and invasion in vitro. PMID: 24146910
42. NDRG2 expression with cell density preceded E-cadherin expression, and the regulation of Snail activity by GSK-3beta was also related to this process. PMID: 23900729
43. the expression of NDRG2 is an independent prognostic factor in pancreatic cancer. PMID: 24134849
44. The present experiments demonstrated that NDRG2 may be a diagnostic and prognostic marker in patients with oesophageal squamous cell carcinoma PMID: 23800335
45. NDRG2 gene expression can be induced by hyperthermia and is correlated with neoplasm invasion in hepatocellular carcinoma. PMID: 23630579
46. findings bring insight to the roles of NDRG2 in ischemic-hypoxic injury and provide potential targets for future clinical therapies on stroke PMID: 23451161
47. NDRG2 gene expression is down-regulated in atypical and recurrent meningiomas. PMID: 20607352
48. These data showed that NDRG2 may play an important role in human lung cancer tumourigenesis PMID: 23307246
49. Our results suggest that the decreased expression of NDRG2 or the increased expression of CD24 is an important feature of lung adenocarcinoma. PMID: 22528516
50. NDRG2 could suppress clear cell renal cell carcinoma cell invasion through regulating MMP-9 expression and activity. PMID: 22692967
顯示更多

收起更多
亞細胞定位：

Cytoplasm. Cytoplasm, perinuclear region. Cell projection, growth cone.
蛋白家族：

NDRG family
組織特異性：

Highly expressed in brain, heart, skeletal muscle and salivary gland, and moderately in kidney and liver. Expressed in dendritic cells, but not in other blood cells. Expression levels are low in pancreatic and liver cancer tissues; absent in meningioma. E
數據庫鏈接：

HGNC: 14460

OMIM: 605272

KEGG: hsa:57447

STRING: 9606.ENSP00000298687

UniGene: Hs.525205

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human